Secondary Hyperparathyroidism clinical trials at UC Davis
1 research study open to eligible people
Studying the Safety and Efficacy of Experimental medicine Hectorol in Pediatric Patients With Chronic Stage 3 and 4 Kidney Disease
“The purpose of this study is to evaluate the possible risks and the effectiveness of Hectorol® in patients ages 5 to 18 years old.”
open to eligible people ages 5-18
Primary Objective: Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH). Secondary Objectives: - Evaluate the safety profile of Hectorol® capsules versus Rocaltrol® (calcitriol) capsules. - Determine the pharmacokinetic profile of 1,25-dihydroxyvitamin D2 after administration of Hectorol®.
Sacramento, California and other locations